CancerNetwork
Oncology On The Go
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more. To learn more, you can also visit us on Face...
Be sure to visit the podcast's website and support the creator: www.cancernetwork.com
Author
CancerNetwork
Category
Podcast website
Latest episode
Nov 16, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
S1 Ep143: Using Multidisciplinary Lifestyle Medicine to Enhance Cancer Survivor QOL 06.01.2025 32:46
In a conversation with CancerNetwork®, Rachel A. Millstein, PhD, MHS; Loren Winters, NP; and Amy Comander, MD, discussed their article titled Implementing a Multidisciplinary Lifestyle Medicine Clinic for Cancer Survivorship, which was published in the November 2024 issue of ONCOLOGY ®. The authors detailed the implementation of a novel oncology-based multidisciplinary lifestyle medicine clinic th...
S1 Ep142: Determining Suitable Radioligand Therapy Use in Neuroendocrine Tumors 30.12.2024 18:46
CancerNetwork® spoke with Natasha Bahri, MD, MS, and Daneng Li, MD, about their Hot Topics article titled Casting a Wide NET: When Is the Optimal Time for 177Lu-Dotatate Treatment?, which was published in the November 2024 issue of ONCOLOGY ®. Their article focused on findings related to the use of 177Lutetium-Dotatate (177Lu-dotatate; Lutathera) in patients with neuroendocrine tumors (NETs) and w...
S1 Ep141: Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations 23.12.2024 8:56
CancerNetwork® spoke with Rachel A. Greenup, MD, MPH, an associate professor of surgery (oncology), section chief of Breast Surgery, and co-director of the Center for Breast Cancer at the Yale School of Medicine, about the rationale behind conducting a study evaluating the lived experiences among women of color following breast cancer mastectomy , as well as data collection strategies employed dur...
S1 Ep140: Highlighting Advocacy Impacts on Funding for Kidney Cancer Research 16.12.2024 12:09
CancerNetwork, in a partnership with KidneyCAN , spoke with 2 genitourinary oncologists, Elizabeth P. Henske, MD, and Jason Muhitch, PhD, about how advocacy and funding through interdisciplinary collaboration between patient advocates, researchers, and physicians have resulted in numerous clinical breakthroughs in kidney cancer. Henske is a professor of medicine at the Harvard Medical School, an...
S1 Ep139: Ensuring Holistic, Individualized Transitions of Care for Cancer Survivors 09.12.2024 16:34
In a conversation with CancerNetwork® at the 2024 Annual Oncology Clinical Practice and Research Summit, Andrew M. Evens, DO, MBA, MSc, spoke about a session he moderated at the meeting, in which he and other panelists highlighted ongoing efforts to improve the quality of care for cancer survivors at his institution. Evens is the deputy director for Clinical Services at Rutgers Cancer Institute a...
S1 Ep138: Managing Risks, Planning Treatment, & Making Progress in Pancreatic Cancer 02.12.2024 25:03
During Pancreatic Cancer Awareness Month , CancerNetwork® spoke with Kelly A. Rone, DNP, RN, AGNP-c, about the current state of pancreatic cancer, emphasizing risk factors, diagnostic challenges, and treatment planning. Rone is an advanced practice nurse of gastrointestinal oncology at Mayo Clinic in Phoenix, Arizona. Rone initially discussed patient counseling for risk factors, making a distincti...
S1 Ep137: Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer 25.11.2024 29:10
In a conversation with CancerNetwork® during Pancreatic Cancer Awareness Month, Tanios S. Bekaii-Saab, MD, spoke about various developments in the pancreatic cancer treatment field. Throughout the discussion, Bekaii-Saab weighed the benefits of currently available chemotherapeutic regimens for patients with metastatic disease, discussed research on the potential for precision medicine in those wit...
S1 Ep136: Collaboration Fosters Treatment Advancements for Young Lymphoma Populations 18.11.2024 20:51
As part of Oncology On the Go , CancerNetwork® spoke with Andrew M. Evens, DO, MBA, MSc, about developments in the treatment landscape for adolescents and young adults (AYA) with lymphoma. He highlighted collaboration between adult and pediatric oncologists that may better standardize treatment for this population. Evens is the deputy director for clinical services at the Rutgers Cancer Institute...
S1 Ep135: Educating Patients and Clinicians on End-of-Life Care and Discussions 11.11.2024 19:05
CancerNetwork® sat down with Kelley A. Rone, DNP, RN, AGNP-c, to discuss the importance of speaking compassionately and ensuring patient awareness when leading end-of-life discussions among those with gastrointestinal (GI) cancers. The discussion also focused on combating burnout in the clinic, using opioids to help manage pain and other symptoms, and educating all members of a multidisciplinary t...
S1 Ep134: Uterine Transposition May Maintain Fertility Following Pelvic Radiotherapy 04.11.2024 13:22
CancerNetwork® spoke with John Paul Diaz, MD, about uterine transposition, a surgical technique aiming to preserve fertility in women undergoing radiotherapy for pelvic tumors. Diaz is the chief of gynecologic oncology, director of robotic surgery, director of the Center of Excellence in Minimally Invasive Gynecologic Surgery at Baptist Health, and lead physician for Clinical Trials in Gynecologic...
S1 Ep133: Empowering Awareness to Address Rising Gynecological Cancer Incidence 28.10.2024 20:00
In a conversation with CancerNetwork®, Ginger J. Gardner, MD, FACOG, spoke about current research and advocacy efforts to improve clinical outcomes among patients with gynecological cancers. With diagnoses of gynecologic malignancies on the rise around the world, Gardner also highlighted the next steps for raising awareness in the field and addressing gaps in care. Gardner is a gynecologic surgeon...
S1 Ep132: Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases 21.10.2024 47:45
In a special co-branded episode between Oncology On the Go hosted by CancerNetwork® and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks, Alexis K. Kuhn, PharmD, BCOP, spoke with Katie Bruce, PharmD, BCPPS, and Susie Long, PharmD, about the use of approved cell-based gene therapies for patients with sickle cell disease, beta thalassemia, adrenoleukodystro...
S1 Ep131: Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma 14.10.2024 21:12
CancerNetwork® collaborated with CURE® to speak with Samantha Shenoy, NP, MSN, a nurse practitioner at the Cancer Immunotherapy Clinic of University of California San Francisco (UCSF) Health, about the role she plays when treating patients with multiple myeloma who are receiving talquetamab-tgvs (Talvey). Of note, emphasis was placed on managing treatment-emergent adverse effects (TRAEs) and toxic...
S1 Ep130: Forming Connections and Making a Difference in the Brain Cancer Field 07.10.2024 20:23
In a conversation with CancerNetwork®, Yoshie Umemura, MD, offered various perspectives on progressing in the brain cancer treatment field. In addition to detailing institution-level advances in delivering multidisciplinary care, she highlighted her personal growth as she advanced in the neuro-oncology field while giving key advice to aspiring researchers who are in the early stages of their caree...
S1 Ep129: Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma 30.09.2024 16:19
CancerNetwork® spoke with James R. Berenson, MD, about the potential role that JAK inhibitors may play in the treatment of patients with multiple myeloma. The conversation focused on the rationale for researching this drug class as well as ongoing initiatives to assess the utility of agents like ruxolitinib (Jakafi) for this patient population. Berenson, founder, medical and scientific director, a...
S1 Ep128: Advancing Glioblastoma Research Through a Phase 3 Niraparib Trial 23.09.2024 20:23
In a conversation with CancerNetwork ®, Nader Sanai, MD discussed the current state of the glioblastoma field, highlighting ongoing research efforts to help improve outcomes among patients with this disease. Sanai is the director of the Ivy Brain Tumor Center and J.N Harber Professor of Neurological Surgery, Francis and Dionne Najafi chair for Neurosurgical Oncology, and chief of neurological onc...
S1 Ep127: Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs 16.09.2024 7:34
In a conversation with CancerNetwork ®, Georgios Evangelou, MD, MSc spoke about his manuscript titled Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs , which he and his coauthors published in the July issue of ONCOLOGY ®. Evangelou, a medical oncologist and consultant in the 3rd Department of Medicine at Sotiria General Hospital in Athens, Greece, reviewed the results of a case st...
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation 09.09.2024 18:53
In a conversation with CancerNetwork®, Jessica Cheng, MD, spoke about her work in the growing field of physical medicine and rehabilitation (PMR) and how it may improve quality of life outcomes among patients with cancer. Above all else, Cheng, an assistant clinical professor in the Department of Supportive Care Medicine at City of Hope, emphasized how supportive care through PMR aims to ensure pa...
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups 02.09.2024 18:21
In a special co-branded episode between Oncology On the Go and the American Society for Transplantation and Cellular Therapy (ASTCT)’s program ASTCT Talks , Rahul Banerjee, MD, FACP, and Noopur Raje, MD, discussed the risk of secondary malignancies in patients with multiple myeloma who receive CAR T-cell therapy. Banerjee is an assistant professor in the Clinical Research Division of Fred Hutchins...
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements 26.08.2024 11:56
In a conversation with CancerNetwork®, Brian A. Van Tine, MD, PhD, spoke about the FDA accelerated approval of afamitresgene autoleucel (afami-cel; Tecelra) for patients with metastatic or unresectable synovial sarcoma expressing MAGE-A4. He discussed the data from the phase 2 SPEARHEAD-1 trial (NCT04044768) supporting the agent’s use in this patient population and highlighted how this approval mi...
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer 19.08.2024 10:56
CancerNetwork® spoke with Ritu Salani, MD, about the expanded FDA approval of dostarlimab-gxly (Jemperli) in combination with carboplatin/paclitaxel for patients with primary advanced or recurrent endometrial cancer.1 Salani, a board-certified gynecologic oncologist and director of Gynecologic Oncology at the University of California, Los Angeles Health, discussed the clinical benefit the dostarl...
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations 12.08.2024 13:49
In a conversation with CancerNetwork ®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer. Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies and a Lavine Family Chair for Preventative Cancer Therapies at Dana-Farber Cancer Institute, and also a professor of...
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy 05.08.2024 28:08
CancerNetwork ® spoke with Kamran Idrees, MD, MSCI, MMHC, FACS; Natalie A. Lockney, MD; and Milad Baradaran, PhD, DABR, about the potential utility of intraoperative radiation therapy (IORT) among patients with pancreatic cancer. The group detailed the design and mechanism, gradual technical advancements, and trial data supporting the application of this radiotherapy modality for this patient popu...
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma 29.07.2024 15:37
In a conversation with CancerNetwork®, Nausheen Ahmed, MD, spoke about optimizing monitoring strategies for patients with B-cell non-Hodgkin lymphoma who undergo treatment with CAR T-cell therapy. Ahmed, an associate professor in the Division of Hematologic Malignancies and Cellular Therapeutics at the University of Kansas Medical Center, discussed the possibility of offering more flexible monitor...
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy 22.07.2024 9:57
At the 2024 Kidney Cancer Research Summit (KCRS), CancerNetwork® spoke with various experts in the kidney cancer field about potential advancements in disease detection and updated efficacy data on immunotherapy and other treatment strategies in patients with renal cell carcinoma (RCC). Karl Semaan, MD, MSc, a postdoctoral oncology research fellow at Dana-Farber Cancer Institute, discussed the imp...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.